Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year ๐Ÿ† (Miller School of Medicine, 2015), the Outstanding Care Award ๐Ÿ… (Sarcoma Alliance, 2012), and the Leadership in Clinical Research ๐ŸŽ–๏ธ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Dr GORDON WEST, Pacific Lutheran University School of Nursing – Tacoma, WA, United States

Dr. Gordon West is a dedicated nurse scientist and healthcare leader with a PhD from the Uniformed Services University (2016) ๐ŸŽ“. He holds an MHA from Baylor University (2006) and a BSN from McMurry University (1998) ๐Ÿฅ. Currently, he is a Research Nurse at The Geneva Foundation-Madigan and an Assistant Professor at Pacific Lutheran University ๐Ÿ“š. With vast experience in military and civilian healthcare, he has led numerous research projects on infection control, patient safety, and military health ๐Ÿฉบ. A Fellow of the American College of Healthcare Executives, he has received multiple awards for nursing research and excellence ๐Ÿ†.

Publication Profile

Google Scholar

Education

Dr. Gordon West ๐ŸŽ“ is a dedicated healthcare professional with a strong academic background. He earned his Ph.D. in 2016 from the Uniformed Services University of the Health Sciences ๐Ÿฅ in Bethesda, MD. Prior to that, he completed his Master of Healthcare Administration (MHA) in 2006 at Baylor University ๐Ÿ›๏ธ in Fort Sam Houston. His journey in healthcare began with a Bachelor of Science in Nursing (BSN) from McMurry University ๐ŸŽ“ in Abilene, TX, in 1998. With extensive education and expertise, Dr. West continues to contribute to the field of healthcare and administration with passion and dedication. ๐Ÿ’‰๐Ÿ“š

Experience

Dr. Gordon West is a dedicated Research Nurse ๐Ÿฉบ at The Geneva Foundation โ€“ Madigan (2023-present) and an Assistant Professor ๐Ÿ“š at Pacific Lutheran University (2022-present). He actively contributes as a Research Board Member at the Washington State Nursing Association & Health Care Council and a Board Member at Rainer Olympic Nurses Association. His extensive military nursing career includes leadership roles at Madigan AMC, Tripler, and Fort Belvoir ๐Ÿฅ, alongside international service in Korea ๐Ÿ‡ฐ๐Ÿ‡ท and Iraq ๐Ÿ‡ฎ๐Ÿ‡ถ. A Ph.D. graduate from USUHS ๐ŸŽ“, he also teaches at Maryville University and Central Michigan University, shaping future nursing professionals. ๐ŸŒŸ

Awards & Honors

Dr. Gordon West has been recognized for his outstanding contributions to nursing and healthcare research ๐Ÿฅ๐Ÿ“š. In 2023, he received a Daisy Nomination from Pacific Lutheran University for his dedication to patient care and nursing excellence ๐ŸŒฟ๐Ÿ†. In 2019, he was honored with the ANCA Nursing Research Award by the Army Nurse Corps Association, highlighting his impactful research in military nursing ๐ŸŽ–๏ธ๐Ÿ”ฌ. That same year, he also received the Excellence in Nursing Research Award from the Defense Health Agency, acknowledging his commitment to advancing healthcare through evidence-based practices and innovation ๐Ÿ…๐Ÿ’ก.

Research Focus

Dr. Gordon B. West’s research explores critical language pedagogy ๐ŸŽ“๐Ÿ“–, focusing on morality, identity, and power in neoliberal English language education ๐ŸŒ๐Ÿ’ฌ. His work critically examines good teacher identities in South Korea ๐Ÿ‡ฐ๐Ÿ‡ท, the politicization of language educators ๐Ÿ—ฃ๏ธโš–๏ธ, and the emotional complexities of critical pedagogy โค๏ธ๐Ÿง . He also investigates sociohistorical perspectives on literacy ๐Ÿ“šโณ and the challenges of critical practitioner research under difficult conditions ๐Ÿ”๐Ÿ› ๏ธ. Through qualitative and materialist approaches, Dr. West sheds light on language education as both a tool for liberation and oppression โœŠ๐Ÿ”—, emphasizing the impact of neoliberalism on English teaching ๐Ÿ’ต๐Ÿซ.

Presentation

Dr. Gordon West is a dedicated nursing researcher focusing on infection control ๐Ÿฆ , patient safety ๐Ÿฅ, and healthcare communication ๐Ÿ“ข. He has presented extensively, including at the Phyllis J. Verhonick Conference (2016) on patient education and fall prevention ๐Ÿฉบ. His work on bacterial contamination of hospital uniforms led to multiple presentations at the American Organization of Nurse Executives Conference (2016-2017) and the Sigma 29th International Nursing Research Conference in Melbourne (2018) ๐ŸŒ. He also explored hands-free communication in nursing at TSNRP (2017). His research enhances clinical safety, infection prevention, and nurse satisfaction, shaping better healthcare practices globally ๐ŸŒ.

Publication Top Notes

Navigating morality in neoliberal spaces of English language education

Young learnersโ€™ portrayals of โ€˜good English teacherโ€™identities in South Korea

Critical practitioner research in language education under difficult circumstances

โ€œHow did you become political?โ€: Narratives of junior researcher-practitioners in applied linguistics

โ€œIs this a safe space?โ€: Examining an emotionally charged eruption in critical language pedagogy

Literacy is a Sociohistoric Phenomenon with the Potential to Liberate and Oppress

Doing critical language pedagogy in neoliberal spaces: A materialist narrative analysis of teaching young learners of English in a Korean hagwon

Positioning of female marriage immigrants in South Korea: a multimodal textbook analysis